A Review on the Role of Irisin in Insulin Resistance and Type 2 Diabetes Mellitus

키워드

참고문헌 (43)

1. Liu JJ, "Lower circulating irisin is associated with type 2 diabetes mellitus", J Diabetes Complications, 27(4), pp.365~369 (2013)
2. Park KH, "Circulating irisin in relation to insulin resistance and the metabolic syndrome", J Clin Endocrinol Metab, 98(12), pp.4899~4907 (2013)
3. Park MJ, "New role of irisin in hepatocytes: The protective effect of hepatic steatosis in vitro", Cell Signal, 27(9), pp.1831~1839 (2015)
4. Zhang Y, "Irisin stimulates browning of white adipocytes through mitogen activated protein kinase p38 MAP kinase and ERK MAP kinase signaling", Diabetes, 63(2), pp.514~525 (2014)
5. Liu S, "Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic β cells", PLoS One, 12(4), pp.e0175498~ (2017)
6. Bostrom P, "A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis", Nature, 481, pp.463~468 (2012)
7. Kozakova M, "Physical activity, adiponectin, and cardiovascular structure and function", Heart Vessels, 28(1), pp.91~100 (2013)
8. Chen N, "Irisin, an exercise-induced myokine as a metabolic regulator : an updated narrative review", Diabetes Metab Res Rev, 32(1), pp.51~59 (2016)
9. Roca-Rivada A, "FNDC5", irisin is not only a myokine but also an adipokine, 2013, pp.8(4), e60563~
10. Schumacher MA, "The structure of irisin reveals a novel intersubunit β-sheet fibronectin (FNIII) dimer: implications for receptor activation", J Biol Chem, 22, pp.33738~33744 (2013)
11. Norheim F, "The effects of acute and chronic exercise on PGC-1alpha, irisin and browning of subcutaneous adipose tissue in humans", FEBS J, 281(3), pp.739~749 (2014)
12. Xu B, "BDNF(I)rising from exercise", Cell Metab, 18(5), pp.612~614 (2013)
13. Moreno-Navarrete JM, "Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance", J Clin Endocrinol Metab, 98(4), pp.769~778 (2013)
14. Zhang Y, "Irisin Stimulates Browning of White Adipocytes through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling", Diabetes, 63(2), pp.514~525 (2014)
15. Rizk FH, "Irisin levels in relation to metabolic and liver functions in Egyptian patients with metabolic syndrome", Can J Physiol Pharmacol, 94(4), pp.359~362 (2016)
16. Jung, UJ, "Obesity and its metabolic complications:the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease", Int J Mol Sci, 15(4), pp.6184~6223 (2014)
17. Liu JJ, "Lower circulating irisin is associated with type 2 diabetes mellitus", J Diabetes Complications, 27(4), pp.365~369 (2013)
18. Gouni-Berthold I, "Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo", PLoS One, 8, pp.e72858~ (2013)
19. Kurdiova T, "Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies", J Physiol, 592(5), pp.1091~1107 (2014)
20. Guilherme A, "Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes", Nat Rev Mol Cell Biol, 9(5), pp.367~377 (2008)
21. Castillo-Quan JI, "From white to brown fat through the PGC-1α-dependent myokine irisin: implications for diabetes and obesity", Dis Model Mech, 5(3), pp.293~295 (2012)
22. Roca-Rivada A, "FNDC5", irisin is not only a myokine but also an adipokine, 2013, pp.8(4), e60563~
23. Yan B, "Association of serum irisin with metabolic syndrome in obese Chinese adults", PLoS One, 9(4), pp.e94235~ (2014)
24. Xiong XQ, "FNDC5 overexpression and irisin ameliorate glucose", lipid metabolic derangements and enhance lipolysis in obesity, 2015, 1867~1875
25. Chen JQ, "Irisin: a new molecular marker and target in metabolic disorder", Lipids in Health and Disease, 14(2), pp.1476~1511 (2015)
26. Fisher FM, "FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis", Genes Dev, 26, pp.271~281 (2012)
27. Liu JJ, "Relationship between circulating irisin, renal function and body composition in type 2 diabetes", J Diabetes Complications, 28(2), pp.208~213 (2014)
28. Park KH, "Circulating irisin in relation to insulin resistance and the metabolic syndrome", J Clin Endocrinol Metab, 98(12), pp.4899~4907 (2013)
29. Tang H, "Irisin inhibits hepatic cholesterol synthesis via AMPK-SREBP2signaling", EBioMedicine, pp.139~148 (2016)
30. Liu TY, "Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K", Akt pathway in type 2diabetic mice and hepatocytes, 2015, pp.129, 839~850
31. Liu S, "Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic β cells", PLoS One, 12(4), pp.e0175498~ (2017)
32. Song H, "Irisin promotes human umbilical vein endothelial cell proliferation through the ERK signaling pathway and partly suppresses high glucose-induced apoptosis", PLoS One, 9(10), pp.e110273~ (2014)
33. Moon HS, "Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines", Metabolism, 62(8), pp.1131~1136 (2013)
34. Lu J, "Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice", Atherosclerosis, 243(2), pp.438~448 (2015)
35. Qiao X, "Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways", Sci Rep, 6, pp.18732~ (2016)
36. Zhu D, "Irisin improves endothelial function in type 2 diabetes through reducing oxidative", nitrative stresses, 2015, pp.87, 138~147
37. Kuloglu T, "Irisin: a potentially candidate marker for myocardial infarction", Peptides, 55, pp.85~91 (2014)
38. Emanuele E, "Serum irisin levels, precocious myocardial infarction, and healthy exceptional longevity", Am J Med, 127(9), pp.888~890 (2014)
39. Aronis KN, "Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events", Int J Obes (Lond), 39(1), pp.156~161 (2015)
40. Aydin S, "Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: cardiac muscle produces more irisin than skeletal muscle", Peptides, 52, pp.68~73 (2014)
41. Qiao X, "Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways", Sci Rep, 6, pp.18732~ (2016)
42. Wu F, "Irisin Induces Angiogenesis in Human Umbilical Vein Endothelial Cells In Vitro and in Zebrafish Embryos In Vivo via Activation of the ERK Signaling Pathway", PLoS One, 10(8), pp.e0134662~ (2015)
43. Zhu D, "Irisin improves endothelial function in type 2 diabetes through reducing oxidative", nitrative stresses, 2015, pp.87, 138~147

관련 논문AI추천